FRANCES DEADMOND: Open Payments
NPI 1255787263 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 89 payments from 14 companies in 2025. Trend: 2023 $1,561 · 2024 $1,658 · 2025 $1,749
Food & beverage: $1,654Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $396 |
| Amgen Inc. | 17 | $253 |
| Janssen Biotech, Inc. | 7 | $205 |
| Galderma Laboratories, L.P. | 11 | $184 |
| Organon LLC | 17 | $170 |
| Regeneron Healthcare Solutions, Inc. | 2 | $110 |
| LEO Pharma Inc. | 1 | $96 |
| UCB, Inc. | 2 | $94 |
| Lilly USA, LLC | 4 | $79 |
| GENZYME CORPORATION | 2 | $51 |
Products named: OTEZLA, TREMFYA, SKYRIZI, RINVOQ, NEMLUVIO, DUPIXENT, ADBRY, Bimzelx.
Industry payments across IL — which companies pay providers there.
